282 related articles for article (PubMed ID: 8864369)
21. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
22. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
24. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
Sartorio A; Conti A; Monzani M
Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
[TBL] [Abstract][Full Text] [Related]
25. Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma.
Sorva R; Turpeinen M; Juntunen-Backman K; Karonen SL; Sorva A
J Allergy Clin Immunol; 1992 Nov; 90(5):808-15. PubMed ID: 1430706
[TBL] [Abstract][Full Text] [Related]
26. Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants.
Namgung R; Tsang RC; Sierra RI; Ho ML
J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):224-8. PubMed ID: 8890070
[TBL] [Abstract][Full Text] [Related]
27. Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group.
Kerstjens HA; Postma DS; van Doormaal JJ; van Zanten AK; Brand PL; Dekhuijzen PN; Koëter GH
Thorax; 1994 Jul; 49(7):652-6. PubMed ID: 8066559
[TBL] [Abstract][Full Text] [Related]
28. Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children.
Bini V; Igli Baroncelli G; Papi F; Celi F; Saggese G; Falorni A
Horm Res; 2004; 61(4):170-5. PubMed ID: 14726619
[TBL] [Abstract][Full Text] [Related]
29. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover.
Schou AJ; Heuck C; Wolthers OD
Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157
[TBL] [Abstract][Full Text] [Related]
31. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
[TBL] [Abstract][Full Text] [Related]
32. Collagen formation and degradation increase during growth hormone therapy in children.
Vihervuori E; Turpeinen M; Siimes MA; Koistinen H; Sorva R
Bone; 1997 Feb; 20(2):133-8. PubMed ID: 9028537
[TBL] [Abstract][Full Text] [Related]
33. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
[TBL] [Abstract][Full Text] [Related]
34. Effects of short-term exposure to high-dose inhaled corticosteroids on novel markers of bone metabolism.
Grove A; McFarlane LC; Jackson CM; Lipworth BJ
Eur J Clin Pharmacol; 1996; 50(4):275-7. PubMed ID: 8803518
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
36. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
Fairfield WP; Sesmilo G; Katznelson L; Pulaski K; Freda PU; Stavrou S; Kleinberg D; Klibanski A
Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832
[TBL] [Abstract][Full Text] [Related]
37. Perinatal collagen turnover markers in intrauterine growth restriction.
Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
[TBL] [Abstract][Full Text] [Related]
38. Levels of bone collagen markers in preterm infants: relation to antenatal glucocorticoid treatment.
Korakaki E; Gourgiotis D; Aligizakis A; Manoura A; Hatzidaki E; Giahnakis E; Marmarinos A; Kalmanti M; Giannakopoulou C
J Bone Miner Metab; 2007; 25(3):172-8. PubMed ID: 17447115
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys.
Wilson ME
J Clin Endocrinol Metab; 2000 Apr; 85(4):1557-62. PubMed ID: 10770197
[TBL] [Abstract][Full Text] [Related]
40. Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men.
Gram J; Junker P; Nielsen HK; Bollerslev J
Bone; 1998 Sep; 23(3):297-302. PubMed ID: 9737353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
